Willis Investment Counsel’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,919
Closed -$976K 119
2022
Q1
$976K Sell
6,919
-354
-5% -$51.7K 0.05% 98
2021
Q4
$1.24M Buy
7,273
+500
+7% +$186K 0.07% 95
2021
Q3
$3.37M Sell
6,773
-510
-7% -$236K 0.19% 79
2021
Q2
$3.65M Buy
7,283
+74
+1% +$39.7K 0.22% 79
2021
Q1
$3.65M Buy
7,209
+3,165
+78% +$1.63M 0.22% 81
2020
Q4
$1.93M Buy
+4,044
New +$1.33M 0.13% 91

Other funds holding AMPE

Willis Investment Counsel's AMPE Position: Q2 2022 in Review

Willis Investment Counsel sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 6,919 shares — an estimated $976K sold.

Willis Investment Counsel first reported a position in AMPE in Q4 2020 and held it in 6 quarters. The position peaked at $3.65M in Q1 2021. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

  • Willis Investment Counsel reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
  • Willis Investment Counsel sold 6,919 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $976K.
  • Willis Investment Counsel first reported a position in Ampio Pharmaceuticals Inc. in Q4 2020 and held it in 6 quarters.
  • Willis Investment Counsel's Ampio Pharmaceuticals Inc. position peaked at $3.65M in Q1 2021.
  • 111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on Willis Investment Counsel's 13F filing for Q2 2022, filed 8 Aug 2022.